[{"id":"6db954e8-43a6-4f85-805a-10d3f605b83c","acronym":"","url":"https://clinicaltrials.gov/study/NCT05783570","created_at":"2023-03-24T16:04:17.343Z","updated_at":"2024-07-02T16:35:14.560Z","phase":"Phase 1","brief_title":"To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307","source_id_and_acronym":"NCT05783570","lead_sponsor":"Eutilex","biomarkers":" IFNG • IL6 • TNFA • GPC3 • IL2 • IL10 • IL18","pipe":"","alterations":" ","tags":["IFNG • IL6 • TNFA • GPC3 • IL2 • IL10 • IL18"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EU307"],"overall_status":"Recruiting","enrollment":" Enrollment 12","initiation":"Initiation: 08/24/2023","start_date":" 08/24/2023","primary_txt":" Primary completion: 06/01/2025","primary_completion_date":" 06/01/2025","study_txt":" Completion: 12/01/2025","study_completion_date":" 12/01/2025","last_update_posted":"2024-03-15"}]